CLINICALLY PROVEN RESULTS IN CHILDREN 1 YEAR AND OLDER
REID AND HIS MOM, JODI
Treating her son's SBS with GATTEX
For children with SBS, GATTEX may reduce parenteral support (PS)
How effective is GATTEX in children?
GATTEX was evaluated in a clinical trial.
In a 6-month study of 59 children (ages 1-17) with SBS who needed PS, the main goal was to determine the ability of GATTEX to reduce weekly PS volume by at least 20% from baseline to week 24. The study also evaluated the average reduction of weekly PS volume from baseline, number of people who reduced PS administration by at least 1 day per week, the average change in hours dedicated to daily PS administration, the number of people who completely stopped PS, and safety.
Trial design for children